Outcome of Movement Disorders affected by Covid-19: case series from a single Movement Disorders Unit
Objective: The aim of this study is to investigate the effects of corona virus (Covid-19) infection on patients with movement disorders. Background: Since the outbreak…Impact of extended quarantine during the COVID-19 pandemic on Parkinson’s disease (PD) patients.
Objective: To determine the impact of extended quarantine during the COVID-19 pandemic in PD patients. Background: Due to the Covid-19 pandemic, various types of social…Progressive encephalomyelitis with rigidity and myoclonus in a Mexican patient
Objective: To present a case report of a Mexican patient with a progressive encephalomyelitis with rigidity and myoclonus (PERM) with a good response to steroids.…Emotional, logistical and ethical aspects of voluntarily stopping eating and drinking in patients with movement disorders
Objective: We present two patients with atypical parkinsonism who chose to die by voluntarily stopping eating and drinking (VSED) to highlight the unique support and care needs associated…Visuo-cognitive training in Parkinson’s disease: Protocol for a randomised cross-over trial.
Objective: To determine the feasibility and potential effects of a technological visuo-cognitive training (TVT) intervention in people with Parkinson’s (PwP). Background: Visual and cognitive impairments…Apomorphine Sublingual Film for “OFF” Episodes in Parkinson’s Disease: Impact of Concomitant Antiemetics on Nausea and Vomiting
Objective: Analyze the effect of concomitant trimethobenzamide (TMB) on nausea and vomiting rates in patients with Parkinson’s disease (PD) receiving apomorphine sublingual film (APL) for…OPTI-ON: A Longitudinal Real-World Study of Opicapone in Patients with Parkinson’s Disease and Motor Fluctuations
Objective: To conduct a longitudinal real-world study that examines treatment patterns, clinical outcomes, safety and tolerability of opicapone as an adjunctive treatment to carbidopa/levodopa (CD/LD)…Apomorphine Sublingual Film for “OFF” Episodes in Parkinson’s Disease: Analysis of Baseline Factors
Objective: Determine if baseline factors are associated with the apomorphine sublingual film (APL) dose required to achieve FULL “ON.” Background: APL is approved for the…The Impact of Visual Cueing on Gait Velocity in those with Parkinson’s Disease with Freezing of Gait
Objective: To determine the ease of use and preliminary effectiveness of shoe-mounted visual cue (laser) on gait velocity in those with Parkinson’s Disease and freezing…Effect of Ketone Ester Supplementation on Motor and Non-Motor symptoms in Parkinson’s Disease
Objective: To investigate the effect of exogenous ketone ester supplementation on motor and non-motor symptoms in Parkinson’s Disease (PD). Background: Animal research and human pilot…
- « Previous Page
- 1
- …
- 12
- 13
- 14
- 15
- 16
- …
- 132
- Next Page »